phosphorylethanolamine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, T | 1 |
| Zhang, C | 1 |
| Liang, XJ | 1 |
| Liang, W | 1 |
| Wu, Y | 1 |
1 other study available for phosphorylethanolamine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antibiotics, Antineoplastic; beta-Cyclodextrins; Carcinoma, Non-S | 2011 |